Literature DB >> 20460526

Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.

Farideh Mehraein-Ghomi1, Hirak S Basu, Dawn R Church, F Michael Hoffmann, George Wilding.   

Abstract

Relatively high oxidative stress levels in the prostate are postulated to be a major factor for prostate carcinogenesis and prostate cancer (CaP) progression. We focused on elucidating metabolic pathways of oxidative stress generation in CaP cells. Previously, we showed that the transcription factor JunD is essential for androgen-induced reactive oxygen species (ROS) production in androgen-dependent human CaP cells. We also recently showed that androgen induces the first and regulatory enzyme spermidine/spermine N1-acetyltransferase (SSAT) in a polyamine catabolic pathway that produces copious amounts of metabolic ROS. Here, we present coimmunoprecipitation and Gaussia luciferase reconstitution assay data that show that JunD forms a complex with androgen-activated androgen receptor (AR) in situ. Our chromatin immunoprecipitation assay data show that JunD binds directly to a specific SSAT promoter sequence only in androgen-treated LNCaP cells. Using a vector containing a luciferase reporter gene connected to the SSAT promoter and a JunD-silenced LNCaP cell line, we show that JunD is essential for androgen-induced SSAT gene expression. The elucidation of JunD-AR complex inducing SSAT expression leading to polyamine oxidation establishes the mechanistic basis of androgen-induced ROS production in CaP cells and opens up a new prostate-specific target for CaP chemopreventive/chemotherapeutic drug development. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460526      PMCID: PMC2909607          DOI: 10.1158/0008-5472.CAN-09-3596

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

Review 1.  The role of oxidative stress in carcinogenesis.

Authors:  James E Klaunig; Lisa M Kamendulis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

Review 2.  The role of oxidative damage and stress in aging.

Authors:  Alex Bokov; Asish Chaudhuri; Arlan Richardson
Journal:  Mech Ageing Dev       Date:  2004 Oct-Nov       Impact factor: 5.432

Review 3.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

Review 4.  Prooxidant states and tumor promotion.

Authors:  P A Cerutti
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

Review 5.  The role of inflammation in the pathogenesis of prostate cancer.

Authors:  William G Nelson; Angelo M De Marzo; Theodore L DeWeese; William B Isaacs
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

6.  Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.

Authors:  M O Ripple; W F Henry; R P Rago; G Wilding
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

Review 7.  Lipid peroxidation--a common pathogenetic mechanism?

Authors:  R Dargel
Journal:  Exp Toxicol Pathol       Date:  1992-08

8.  Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells.

Authors:  Natalia A Ignatenko; Naveen Babbar; Dipti Mehta; Robert A Casero; Eugene W Gerner
Journal:  Mol Carcinog       Date:  2004-02       Impact factor: 4.784

Review 9.  Reactive oxygen species in tumorigenesis.

Authors:  D I Feig; T M Reid; L A Loeb
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

Review 10.  Endocrine control of prostate cancer.

Authors:  G Wilding
Journal:  Cancer Surv       Date:  1995
View more
  17 in total

1.  Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancer.

Authors:  Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 2.  Reactive oxygen species in eradicating acute myeloid leukemic stem cells.

Authors:  Hui Zhang; Hai Fang; Kankan Wang
Journal:  Stem Cell Investig       Date:  2014-06-07

3.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

4.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

5.  Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis.

Authors:  Wei Huang; Jens C Eickhoff; Farideh Mehraein-Ghomi; Dawn R Church; George Wilding; Hirak S Basu
Journal:  Prostate       Date:  2015-04-20       Impact factor: 4.104

6.  A microfluidic coculture and multiphoton FAD analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells.

Authors:  Lauren L Bischel; Benjamin P Casavant; Pamela A Young; Kevin W Eliceiri; Hirak S Basu; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2014-06       Impact factor: 2.192

Review 7.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

8.  The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells.

Authors:  Eric M Lewis; Amanda S Wilkinson; Jacqueline S Jackson; Rohit Mehra; Sooryanarayana Varambally; Arul M Chinnaiyan; John C Wilkinson
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

9.  Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression.

Authors:  Farideh Mehraein-Ghomi; Stacy J Kegel; Dawn R Church; Joseph S Schmidt; Quentin R Reuter; Elizabeth L Saphner; Hirak S Basu; George Wilding
Journal:  Prostate       Date:  2014-03-20       Impact factor: 4.104

10.  Distinct redox profiles of selected human prostate carcinoma cell lines: implications for rational design of redox therapy.

Authors:  Luksana Chaiswing; Weixiong Zhong; Terry D Oberley
Journal:  Cancers (Basel)       Date:  2011       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.